Literature DB >> 12435163

Rheumatoid arthritis: principles of early treatment.

Barry Bresnihan1.   

Abstract

Early diagnosis and effective treatment is considered to be important in the prevention of joint damage and disability in patients with rheumatoid arthritis (RA). This hypothesis has led to the establishment of special early arthritis clinics in many centers. The lag times between onset of symptoms of RA and diagnosis, and the introduction of disease modifying antirheumatic drugs, have been greatly reduced. Treatment strategies have become increasingly refined. Moreover, newer therapies have increased the options for limiting early joint damage and subsequent disability.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12435163

Source DB:  PubMed          Journal:  J Rheumatol Suppl        ISSN: 0380-0903


  5 in total

1.  Sonography and subclinical synovitis.

Authors:  B Bresnihan; D Kane
Journal:  Ann Rheum Dis       Date:  2004-04       Impact factor: 19.103

2.  Ethanol extract of Angelica gigas inhibits croton oil-induced inflammation by suppressing the cyclooxygenase - prostaglandin pathway.

Authors:  Sunhee Shin; Seong Soo Joo; Dongsun Park; Jeong Hee Jeon; Tae Kyun Kim; Jeong Seon Kim; Sung Kyeong Park; Bang Yeon Hwang; Yun-Bae Kim
Journal:  J Vet Sci       Date:  2010-03       Impact factor: 1.672

3.  Efficacy and safety of tofacitinib following inadequate response to conventional synthetic or biological disease-modifying antirheumatic drugs.

Authors:  Christina Charles-Schoeman; Gerd Burmester; Peter Nash; Cristiano A F Zerbini; Koshika Soma; Kenneth Kwok; Thijs Hendrikx; Eustratios Bananis; Roy Fleischmann
Journal:  Ann Rheum Dis       Date:  2015-08-14       Impact factor: 19.103

Review 4.  Ultrasound of the small joints of the hands and feet: current status.

Authors:  E G McNally
Journal:  Skeletal Radiol       Date:  2007-08-22       Impact factor: 2.199

Review 5.  Are synovial biopsies of diagnostic value?

Authors:  Barry Bresnihan
Journal:  Arthritis Res Ther       Date:  2003-10-02       Impact factor: 5.156

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.